Missouri House Refuses to Accept Senate Amendments on Prescription Drug Monitoring
From Missouri Digital News: https://mdn.org
MDN Menu

MDN Home

Journalist's Creed

Print

MDN Help

MDN.ORG: Missouri Digital News
MDN Menu

MDN Home

Journalist's Creed

Print

MDN Help

MDN.ORG Mo. Digital News Missouri Digital News MDN.ORG: Mo. Digital News MDN.ORG: Missouri Digital News
Lobbyist Money Help  

Missouri House Refuses to Accept Senate Amendments on Prescription Drug Monitoring

Date: April 18, 2017
By: Jack Morrisroe
State Capitol Bureau
Links: HB 90

Intro: 
The Missouri House did not agree with Senate amendments to a prescription drug monitoring program, including checking for only opioids and purging data after half a year.
RunTime: 0:40
OutCue:  SOC

Wrap: The bill sponsor, Representative Holly Rehder, said the Senate version would not stop Missourians addicted to prescription drugs from relapsing.

Actuality:  REHDER2.WAV
Run Time: 00:10
Description: When you're looking at addiction, your first two years you have more relapses and once you get past that two-year mark you're doing pretty good.

Opponents said the program has not been successful in other states and will harm the privacy of Missourians.

The Senate passed the prescription drug monitoring program after over three hours of debate last week. A conference committee is expected to debate the measure before it is returned to both legislative bodies.

Reporting from the state Capitol, I'm Jack Morrisroe.

Intro: 
The Missouri House voted Tuesday to not accept the Senate version of prescription drug monitoring.
RunTime: 0:39
OutCue:  SOC

Wrap: Lake St. Louis Representative Justin Hill said the Senate's version was the best balance of protecting Missourians' privacy and working to curb opioid addiction.

Actuality:  HILL2.WAV
Run Time: 00:09
Description: At least people that don't abuse drugs would have the ability or the comfort of knowing that their information isn't kept in perpetuity.

Bill sponsor and Republican Representative Holly Rehder did not agree with the Senate amendments requiring data be deleted after one-hundred and eighty days and monitoring only opioids and drugs reactive to them.

The measure will now go to a conference committee of representatives and senators.

Reporting from the state Captiol, I'm Jack Morrisroe.